Back to companies

Stada Arzneimittel AG: Premium Databases

Stada Arzneimittel AG Catalyst Calendar

Proactively evaluate Stada Arzneimittel AG’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Stada Arzneimittel AG Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 15+ results. Subscribe to unlock more.
30 Jun 2021 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
17 Jun 2021 Phase III Trial Completion AIM Foundation; Barts Charity; Barts Health NHS Trust; Cytoplan Ltd; DSM Nutritional Products Ltd; Fischer Family Trust; Hyphens Pharma Pte Ltd; NIHR Clinical Research Network; Pharma Nord (UK) Ltd; Queen Mary University of London; Synergy Biologics Ltd; Thornton & Ross Ltd - cholecalciferol Infectious Disease; Respiratory Coronavirus Disease 2019 (COVID-19); Respiratory Tract Infections Clinical Trial Registry
11 May 2021 Phase III Trial Completion Stada Arzneimittel AG; Syneos Health Inc; Xbrane Biopharma AB SYNH; XBRANE ranibizumab biosimilar Metabolic Disorders; Ophthalmology Age Related Macular Degeneration; Diabetic Macular Edema; Diabetic Retinopathy; Macular Degeneration; Wet (Neovascular / Exudative) Macular Degeneration Clinical Trial Registry
31 Dec 2020 Phase II Trial Completion Nizhpharm - meloxicam; thiocolchicoside Central Nervous System Low Back Pain; Neck Pain (Cervicalgia); Pain Clinical Trial Registry
Catalyst Calendar


Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.



  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)


Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer